We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
-14.37%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$4.54B
AUM Growth
+$253M
Cap. Flow
+$1.18B
Cap. Flow %
25.96%
Top 10 Hldgs %
33.8%
Holding
1,175
New
218
Increased
613
Reduced
164
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 11.33%
2 Consumer Discretionary 7.6%
3 Consumer Staples 5.46%
4 Financials 5.09%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMD icon
226
Advanced Micro Devices
AMD
$798B
$1.85M 0.04%
24,156
+4,180
+21% +$391K
ABB
227
DELISTED
ABB Ltd
ABB
$1.81M 0.04%
67,820
+19,487
+40% +$579K
PRI icon
228
Primerica
PRI
$10.2B
$1.81M 0.04%
15,117
-1,492
-9% -$188K
ICE icon
229
Intercontinental Exchange
ICE
$84.1B
$1.81M 0.04%
19,242
+3,270
+20% +$350K
AON icon
230
Aon
AON
$76.5B
$1.79M 0.04%
6,638
-1,355
-17% -$389K
TSCO icon
231
Tractor Supply
TSCO
$17.9B
$1.75M 0.04%
45,135
+6,525
+17% +$265K
SHW icon
232
Sherwin-Williams
SHW
$88.2B
$1.73M 0.04%
7,744
+829
+12% +$213K
MU icon
233
Micron Technology
MU
$996B
$1.7M 0.04%
30,815
+1,927
+7% +$131K
ATVI
234
DELISTED
Activision Blizzard
ATVI
$1.7M 0.04%
21,853
-652
-3% -$50.7K
ROP icon
235
Roper Technologies
ROP
$39.3B
$1.67M 0.04%
4,238
-59
-1% -$25.7K
MMM icon
236
3M
MMM
$93.2B
$1.67M 0.04%
15,409
+8,409
+120% +$1.02M
AZN icon
237
AstraZeneca
AZN
$250B
$1.66M 0.04%
12,582
+1,619
+15% +$212K
MMP
238
DELISTED
Magellan Midstream Partners, L.P.
MMP
$1.65M 0.04%
34,447
+3,297
+11% +$165K
EW icon
239
Edwards Lifesciences
EW
$51.5B
$1.64M 0.04%
17,204
-3,687
-18% -$382K
BMY icon
240
Bristol-Myers Squibb
BMY
$131B
$1.63M 0.04%
21,097
+14,142
+203% +$1.08M
MET icon
241
MetLife
MET
$64.3B
$1.61M 0.04%
25,611
+1,920
+8% +$127K
MTB icon
242
M&T Bank
MTB
$36.1B
$1.6M 0.04%
10,065
+1,604
+19% +$270K
COP icon
243
ConocoPhillips
COP
$142B
$1.58M 0.03%
17,644
+10,977
+165% +$1.13M
SBCF icon
244
Seacoast Banking Corp of Florida
SBCF
$3.34B
$1.58M 0.03%
+47,805
New +$1.6M
FSLR icon
245
First Solar
FSLR
$26.2B
$1.58M 0.03%
23,183
-3,218
-12% -$229K
ENPH icon
246
Enphase Energy
ENPH
$5.24B
$1.57M 0.03%
8,060
-1,165
-13% -$211K
XYL icon
247
Xylem
XYL
$28.2B
$1.56M 0.03%
19,980
-7,216
-27% -$596K
ARKK icon
248
ARK Innovation ETF
ARKK
$6.01B
$1.55M 0.03%
38,991
+27,415
+237% +$1.31M
GWW icon
249
W.W. Grainger
GWW
$60.4B
$1.54M 0.03%
3,394
+138
+4% +$67.1K
EWQ icon
250
iShares MSCI France ETF
EWQ
$343M
$1.53M 0.03%
+50,976
New +$1.67M

Similar funds

Pathstone Family Office's Q2 2022 Portfolio in Review

As of Q2 2022, Pathstone Family Office held 1,175 positions worth $4.54B, up 5.9% from $4.29B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Pathstone Family Office deployed $1.18B of net new capital in Q2 2022, opening 218 new positions and adding to 613 existing holdings. Its largest new stake was Dimensional World ex US Core Equity 2 ETF: 3,460,856 shares worth $74.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Elevance Health, an estimated $140M trimmed.

  • Pathstone Family Office's largest Q2 2022 buy was Dimensional World ex US Core Equity 2 ETF: 3,460,856 shares worth $74.2M.
  • Pathstone Family Office added most to Coca-Cola in Q2 2022, an estimated $172M increase.
  • Pathstone Family Office's biggest Q2 2022 reduction was Elevance Health, cutting an estimated $140M.
  • Pathstone Family Office fully exited Schwab US REIT ETF in Q2 2022, selling an estimated $4.41M.
  • Pathstone Family Office's ten largest holdings make up 34% of its $4.54B portfolio in Q2 2022.
  • Pathstone Family Office opened 218 new positions and closed 126 in Q2 2022.
  • Pathstone Family Office's portfolio value rose 5.9% quarter-over-quarter to $4.54B.

Based on Pathstone Family Office's 13F filing for Q2 2022, filed 15 Aug 2022.